Kidney cancer: post-surgery sorafenib
0 Visninger
• 06/26/23
0
0
Indlejre
administrator
Abonnenter
Tim Eisen, MBBChir, PhD, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK, describes the rationale and methodology behind the SORCE trial (NCT00492258) and what have we learned at the European Society for Medical Oncology (ESMO) 2019 congress in Barcelona, Spain.
Vis mere
Facebook kommentarer
SORT BY-
Topkommentarer
-
Seneste kommentarer